s6y
Company name or ticker
Search
SYNAGEVA BIOPHARMA CORP
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Monday, June 13, 2011
Accession number
0001193125-11-163557
Documents
FORM 8-K
425
PRESS RELEASE
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header